Armata Pharmaceuticals (ARMP) EBT: 2013-2024
Historic EBT for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$53.2 million.
- Armata Pharmaceuticals' EBT rose 53.19% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$15.9 million, marking a year-over-year decrease of 63.16%. This contributed to the annual value of -$53.2 million for FY2024, which is 22.71% down from last year.
- According to the latest figures from FY2024, Armata Pharmaceuticals' EBT is -$53.2 million, which was down 22.71% from -$43.3 million recorded in FY2023.
- Armata Pharmaceuticals' 5-year EBT high stood at -$22.2 million for FY2020, and its period low was -$53.2 million during FY2024.
- Over the past 3 years, Armata Pharmaceuticals' median EBT value was -$43.3 million (recorded in 2023), while the average stood at -$44.5 million.
- Data for Armata Pharmaceuticals' EBT shows a maximum YoY crashed of 54.35% (in 2022) over the last 5 years.
- Yearly analysis of 5 years shows Armata Pharmaceuticals' EBT stood at -$22.2 million in 2020, then fell by 7.80% to -$23.9 million in 2021, then crashed by 54.35% to -$36.9 million in 2022, then decreased by 17.39% to -$43.3 million in 2023, then dropped by 22.71% to -$53.2 million in 2024.